Etiotropic treatment of patients with influenza type A. Pathogenetic and symptomatic therapy
Year: 2018
Type: article
Abstract: Traditionally the influenza is an important problem of modern medicine. The risk is determined primarily by the severity of the complications, in some cases, exacerbates chronic somatic diseases. This requires the use for the treatment of antiviral drugs with direct antiviral effect. The list of their very limited there are two main groups of drugs having direct antiviral effects: blockers of M2-channels (rimantadine) and neuraminidase inhibitors (oseltamivir, zanamivir).The aim of the study was to examine the effectiveness of remavir/rimantadine in patients with moderate course of influenza and its outcomes.Materials and methods. It was examined 28 patients with influenza, who received rimantadine scheme with no hereditary history, 18 patients with influenza a (control group) was administered pathogenetic and symptomatic therapy.Results. Confirmed the positive impact of remavir on the course of influenza. Its inclusion in the treatment of patients with the moderate course led to a statistically significant reduction in the duration of symptoms of intoxication and catarrhal symptoms, reduce the incidence of complications. Tolerability is good no side effects were recorded.Conclusion. Аntiviral remantadin’s therapy of influenza is effective still: at the patients with a moderate course a therapy has been resulted in a shortening of intoxication syndrome and catarrhal phenomenon, and for the increase of frequency complications too. If necessary, patients are shown adequate pathogenetic and symptomatic therapy
Source: Medicine of Ukraine
Author: V. P. Maliy
Institution: Kharkiv Medical Academy of Postgraduate Education
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W3097232195